Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Formoterol (6mcg) + Fluticasone Propionate (50mcg) Inhaler
Therapeutic Category
Asthma, General and OTC medicines, Pulmonary, Respiratory
Dosage Form
Inhaler
Packaging Type
Packaging
120 Metered Dose
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Flutialfa F 50 Inhaler combines two active ingredients, Formoterol (6mcg) and Fluticasone Propionate (50mcg), in a single inhaler for the effective management of respiratory conditions such as Asthma and Chronic Obstructive Pulmonary Disease (COPD). Formoterol, a long-acting beta-agonist (LABA), helps relax and open the airways, making it easier to breathe. Fluticasone Propionate, a corticosteroid, works by reducing inflammation in the airways, thus preventing symptoms like wheezing, coughing, and shortness of breath.
This combination therapy offers a comprehensive approach to managing asthma and COPD, as it addresses both the inflammation and bronchoconstriction that contribute to these conditions. By combining a corticosteroid and a long-acting beta-agonist, Flutialfa F 50 Inhaler provides both immediate relief from bronchospasm and long-term control of symptoms. It is typically used for the maintenance treatment of asthma in patients who require both a long-term controller and a bronchodilator.
Common side effects include headache, throat irritation, hoarseness, and oral candidiasis.
For the maintenance treatment of Asthma and COPD in patients requiring both a corticosteroid and a long-acting beta-agonist.
Not for acute asthma attacks; follow the prescribed dosage and instructions from your healthcare provider.
Store at room temperature, below 30°C, away from moisture, and out of the reach of children.
Composition : Budesonide (200mcg) Inhaler
Composition : Beclomethasone Dipropionate 50 mcg + Levo Salbutamol 50 mcg Inhaler
Composition : Tiotropium (9mcg) Inhaler
Composition : Tiotropium (18mcg)
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Salmeterol (25mcg) + Fluticasone Propionate (125 mcg) Inhaler
Composition : Formoterol (6mcg) + Tiotropium (9mcg)
Composition : Salbutamol (100mcg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Formoterol 6 mcg + Fluticasone Propionate 50 mcg Inhaler is a combination inhalation therapy used for the long-term management of asthma and Chronic Obstructive Pulmonary Disease (COPD). Formoterol is a long-acting beta-2 agonist (LABA) that provides rapid and prolonged bronchodilation, helping patients breathe more easily. Fluticasone Propionate is an inhaled corticosteroid (ICS) that reduces airway inflammation and helps prevent asthma attacks and COPD exacerbations. This combination offers effective symptom control and long-term respiratory management, making it a highly demanded product in the pulmonology and respiratory care segment.
Medical distributors and wholesalers can benefit from continuous demand from pulmonologists, chest physicians, pediatricians, and general practitioners. Since asthma and COPD require ongoing maintenance therapy, inhalers generate regular refill prescriptions, repeat sales, and long-term customer retention.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in respiratory, pulmonology, and inhalation therapy segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high chronic disease prevalence, specialist-driven prescriptions, and long-term treatment continuity, making it a stable, high-value, and repeat-order pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in respiratory and inhalation therapy products can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the pulmonology and respiratory care segment.